We have investigated the transcription factor requirements for basal expression of the mouse pS3 promoter by using a combination of reporter and electrophoretic mobility shift assays (EMSAs). We have found that only four regions of the promoter bind transcription factors in EMSAs, suggesting that these are the only Important factors for basal transcription. These factors are NF1, USF, ETF-IIke and a novel factor which we have called PF2. Construction of promoter deletion mutants has shown that the absence of the PF2 site completely inactivates the promoter, whereas deletion of other sites, whilst reducing promoter activity, does not. We suggest that this novel transcription factor (PF2) is critical for expression of the mouse p53 promoter.
INTRODUCTION
It is now clear from different lines of evidence that the p53 gene encodes a protein product which can act as a tumour suppressor (1, 2) . The p53 protein is thought to act as a monitor of chromosome damage (3) which causes growth arrest in response to genotoxic agents (4, 5) , presumably allowing time for DNA repair to occur. In this way p53 prevents mutations being transmitted to daughter cells in each division cycle. Mutations in thep5J gene, which often render the p53 protein defective, are so frequent in human cancers (6) that they are presently recognized as the most common genetic alteration amongst human and animal malignancies.
In comparison with studies of the protein, there is only a modest literature on transcriptional regulation of the p53 gene. Unlike many genes transcribed by RNA polymerase II, the p53 promoter does not contain recognizable TATA and CAAT motifs upstream of the transcription start site (7) . There is, however, a region extending from -2 to +5 bp which has homology with the Lnr (initiator) element (8, Fig. 1 ), which has been shown to position the start site of transcription in TATA-less promoters (9) . Adjacent to the Inr is an NF1 -like binding site (+5 to +17 bp, Fig.  1 ), which has been shown to bind NF1 (10) . There is also a GC-rich stretch upstream of the Inr which contains a potential Spl binding site (-44 to -50 bp, Fig. 1 ), but there is no direct evidence that Spl, or indeed any factor, binds this region, although the sequence is conserved across species (7) . Upstream GC-rich sequences, including Spl binding sites, are a common feature of TATA-less promoters (11) . Downstream of the Inr is the sequence motif C ACGTG (+70 to +75 bp, Fig. 1 ), which matches the consensus binding sequence for the basic helix-loop-helix (bHLH) family of transcnptional activators. This sequence appears to be important for basal expression of \htp53 promoter, because its deletion reduces promoter activity 5-fold in transient expression assays (12) . One member of the bHLH family, known as USF, has been shown to bind this motif and in co-transfection studies a plasmid expressing USF enhances p53 promoter activity (13) . In addition, transcription factors Myc and Max, which are also members of the bHLH family, form a heterodimer and bind the CACGTG motif. Over-expression of c-myc in transfection experiments also enhances p53 promoter activity (14) .
p53 mRNA levels are elevated in response to serum growth factors (15) , lectins (16) , phorbol esters (10) and infection with viruses, including S V40 (17) and adenovirus (18) . Transactivation by phorbol esters appears to be mediated through the sequence motif CTGACTCT (-64 to -57 bp, Fig. 1 ), which is an AP-1-like binding site. However, purified AP-1 protein did not bind this motif and the binding activity was not competed with consensus AP-1 ohgonucleotides (10). This 'AP-1-like' activity has been designated PF1 (p53 Factor 1) (10). Transactivation of the p53 promoter after adenovirus infection is caused by Ela gene products (18) , but as yet no El a response element has been reported.
In this paper, we have studied the regulation of transcription of the mouse p53 promoter in transfected cells under low serum conditions to explore the transcription factor requirements for basal gene expression. Studies to be reported elsewhere have explored the transcription factor requirements under activating conditions (T. K. Hale and A. W. Braithwaite, in preparation). We have used electrophoretic mobility shift assays to identify regions within this p53 promoter that bind potential transcription factors and then used oligonucleotide competition studies to identify these factors. In some cases, the binding sites for these transcription factors have been deleted and the effect of the deletions on promoter activity determined. Importantly, we have identified a region (-195 to -165 bp) that is critical for p53 promoter activity and which appears to bind a novel transcription factor. 
MATERIALS AND METHODS

Cell culture
Human HeLa, monkey CV1, mouse L929 and normal rat kidney (NRK) cell lines were maintained at 37° C, 5% CO2 in minimal essential medium (EMEM; Trace BioSciences, USA) supplemented with 10% foetal calf serum (FCS). Rat embryo fibroblasts (REFs) were prepared as described previously (19) and routinely cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL, USA) containing 10% FCS and 0.45% glucose. REFs were used up to passage 7 and then replaced with new cells.
Plasmids
The plasmid pCAT3M contains the CAT gene, but no eukaryotic promoter sequences upstream of this gene (20) . pAACAT (7) contains -225 to +117 bp of the mouse p53 promoter blunt-end cloned in front of the CAT gene in pCAT3M. The plasmid pARCAT (7) contains -320 to +117 bp of the mouse p53 promoter also blunt-end cloned in front of the CAT gene in pCAT3M.
Mammalian cell transfection
For most cell types, 10 6 cells growing in a 100 mm dish were transfected using the calcium phosphate method (21) with the Transfinity™ kit from BRL (USA). Ten u.g of plasmid DNA was used to transfect each 100 mm dish of cells. For NRK cells, 4 (ig LipofectAMTNE™ (Gibco-BRL, USA) was used with 16 (ig of reporter plasmid, as calcium phosphate was found to be toxic to NRK cells. In general, we found NRK cells difficult to transfect without toxic side effects, no matter what technique was employed. Hence, most transfection experiments were done using REFs.
CAT assay
Sixty hours after transfection cells were washed twice in ice-cold PBS and harvested by scraping into 1 ml of ice-cold PBS, centrifuged, then resuspended in 100 uJ of 0.25 M Tris-HCl, pH 7.5. Extracts of transfected cells were then prepared by three rounds of freezing and thawing followed by centrifugation for 15 min at 12 000 g and 4°C to remove cellular debris. The supernatant was then heated to 65°C for 10 min to inactivate a CAT inhibitor previously reported by Sleigh (22) . Cell lysates were then normalized for protein content and CAT activities determined essentially as described by Sleigh (22) . Details of this procedure have been described previously (23) .
Preparation of nuclear extracts
Nuclear proteins were isolated from subconfluent monolayers of NRK cells using a modified small-scale preparation method described by Schreiber (24) . Monolayers from 100 mm dishes were washed twice with cold PBS, harvested by scraping and transferred to microfuge tubes. Cells were centifuged at 13 000 r.p.m for 10 s and resuspended in 400 (i.1 of cold buffer A (10 mM HEPES, pH 7.9, 10 mM KC1,0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF). Cells were allowed to swell for 15 min on ice, after which 25 yl of 10% NP^tO (Fluka) was added and vigorously vortexed for 10 s. Homogenates were then centrifuged for 30 s at 13 000 r.p.m., 4°C to pellet the nuclei, which were resuspended in 50 |J.l ice-cold buffer C (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF) and rotated for 15 mm at 4°C. Nuclear extracts were centrifuged for 5 min at 4°C and the supernatant dialysed against 100 vol of buffer D (20 mM HEPES, pH 7.9, 20% glycerol, 0.1 M KC1,0.2 mM EDTA, 0.5 mM PMSF, 0 5 mM DTT) for 18 h at4°C
Electrophoretic mobility shift assays (EMSA)
Binding reactions were performed in a volume of 15 (il containing 15-35 ug nuclear extract, 0.5-2 u.g poly(dI-dC)poly(dI-dC), 10 mM Tris-HCl, pH 7.5,50 mM NaCl, 1 mM MgCl 2 ,0.5 mM DTT, 0.5 mM EDTA, 4% glycerol. Reactions were allowed to proceed for 15 min at room temperature (RT). target oligonucleotide (1 x 10 4 c.p.m.), end-labelled with [ 32 P]dCTP, was added to the binding reaction and incubated at RT for a further 15 mm. Following this, 1.5 ^1 of loading dye was added and the binding reaction was immediately loaded onto a pre-electrophoresed 5% polyacrylamide gel. After electrophoresis, gels were fixed in 10% acetic acid for 10 min, dried for 30 min at 80°C and exposed to Kodak X-omat AR film at -70°C, usually for 7-14 h. For competition EMSAs, unlabelled oligonucleotides were added to the binding reactions prior to addition of the radiolabelled oligonucleotide.
Construction of mouse p53 promoter deletion mutants
In order to create specific deletion mutants within the mouse p53 promoter, the technique of inverse polymerase chain reaction (PCR) was used (25) . This involves designing primer pairs which are in opposite orientation, the 5' ends of which define the boundaries of the sequence to be deleted. Amplification then occurs in opposite directions, copying the entire plasmid except for the region between the 5' ends of the primers, this being the required deletion. The PCR products are then directly ligated and transformed into bacteria.
In this instance, for thep53 promoter the following primer pairs were synthesised: 5'-ATCTTAGACGACTTTTCACAAAGCG TTC-3' and 5'-AAGAATTAAGTTTTTATCGTAAGTGGACC-3' for pAl+2cat; 5'-TGCrGAGGGCAACATCTCAGGGAGAAT-3' and 5'-ATAGAGCTGTGAGGGCAAAATGGGTGG-3' for pA3cat; 5'-CCCCGCCTCCATTTCiTGCCCTCA-3' and 5'-GG AACGCTTTGTGAAAAGTCGTCTAAG-3' for pA4cat; 5'-CT TGTTATGGCGACTATCCAGCTTTG-3' and 5'-ACTTGCAG AGTCAGGATTCTCCCTG-3' for pA5cat. PCR was performed with one cycle at 96°C for 3 min, 65°C for 15 s and 72°C for 5 mm, followed by 25 cycles at 96 °C for 3 min, 65 °C for 15 s and 72°C for 5 nun, then one cycle of 72°C for 9 min was done in 50 uJ of reaction mixture containing 20 mM Tris-HCl, pH 8.8, 10 mM KC1, 10 mM (NRO2SO4, 2-10 mM MgSO 4 , 0.1% Triton X-100, 100 uM each of dNTPs, 10 ng template pAACAT, 40 pmol each of the primers and 0.5 U Vent DNA polymerase (New England Biolabs)
The amplified linear DNA was agarose gel-purified, T4 kinase-treated and then a portion was self-hgated in 15 mM Tris-HCl, pH 7.8, 5 mM MgCl 2 , 5 mM DTT, 0.25 mM ATP, 30 mM KC1,1 mM hexamine cobalt chloride and 8 U T 4 DNA ligase at 14°C for 16 h and used to transform competent Eschenchia coli DH5 cells. The deletions generated were all confirmed by sequencing.
RESULTS
Cell type-dependent expression of the mouse p53 promoter
To determine in which cell types the mouse p53 promoter is active, HeLa, CV1, L929, NRK cells and REFs were transfected with the constructs pAACAT, pARCAT and pCAT3M. Plasmid pAACAT contains -225 to +117 bp of the mouse p53 promoter linked to the CAT reporter gene in the vector pCAT3M and pARCAT contains a longer region (-320 to +117 bp) of the promoter cloned adjacent to the CAT gene in the same vector. These constructs have been described previously (7) . Sixty hours post-transfection cells were harvested, lysates prepared, normalized for protein content and CAT activities determined as described. Results (Fig. 2) showed that only in the rodent cells were the promoter-containing constructs expressed significantly more (4-8-fold) than the vector control. By contrast, in CV1 and HeLa cells the increased CAT activities relative to the vector were at best 40%. In addition, pARCAT and pAACAT showed similar levels of promoter activity in REFs, but pARCAT was expressed slightly less well than pAACAT in NRK and L929 cells. These data are consistent with there being a negative regulatory element present between -320 and -225 bp, as previously reported (7). However, in numerous repeat experiments in both L929 and REFs, including dose experiments (data not shown), we were not able to obtain reproducible evidence of an upstream negative regulatory element
We conclude from these experiments that the mouse p53 promoter is only efficiently expressed in rodent cells and there appears to be no convincing evidence of a negative regulatory element present within this promoter.
Three regions of the mouse p53 promoter bind transcription factors
In order to identify regions of the mouse p53 promoter which bind transcription factors, a set of seven partially overlapping doublestranded oligonucleotides were synthesized that span the region -224 to +101 bp of the mouse p53 promoter (Fig. 3) . This region essentially contains all the promoter sequence that is necessary for full promoter activity in our experiments (Fig. 2) . The oligonucleotides were then radiolabelled in vitro and used in EMSAs with nuclear extracts prepared from NRK cells. Results from these experiments showed that oligomer 1 (-224 to -16 bp), oligomer 6 (-5 to +5 bp) and oligomer 7 (+48 to +10 bp) bound protein factors, whilst other ohgomers did not (Fig. 3) , including ohgomers 4 and 5 (together spanning -92 to -1 bp) which reportedly contain PF1 and Spl sites respectively (Fig. 1) . These data suggest therefore that only the three regions defined by oligomer 1, oligomer 6 and oligomer 7 of the mousep53 promoter contain important regulatory elements for transcription under the low serum conditions used in our experiments. Our data do not provide evidence for the involvement of Spl or PF1 in the basal transcriptional regulation of this promoter.
Oligomers 6 and 7 bind NF1, USF and an ETT-like factor
In order to identify which transcription factors bind oligomers 6 and 7, these oligomers were radiolabelled and a series of competition EMSAs carried out with non-radioactive oligomers containing consensus DNA binding sites for known transcription factors. Results (Fig. 4) show that oligomer 6 factor binding is abolished in the presence of 'self ' (unlabelled oligomer 6) and even better with an oligomer containing the consensus sequence for NF1 The self oligomer contains an 11/13 nucleotide match to the NF1 consensus oligomer. Thus, the observation that the NF1 oligomer competed more effectively than the self oligomer suggests that the DNA binding activity detected here has a higher affinity for the NF1 consensus sequence. This is consistent with it being NF1, although formal proof would require the use of an antibody to NF1. No competition was observed with oligomers containing consensus DNA binding sites for USF or TFIID ( Fig  4A) or for several other transcription factors (data not shown). We conclude that NF1 binds oligomer 6, consistent with previous observations (10), but we cannot exclude the possibility that it is an NF1 -related factor.
An EMSA carried out with oligomer 7 shows the presence of two retarded DNA-protein complexes designated 7A and 7B and competition studies showed that both complexes were abolished in the presence of excess self (unlabelled oligomer 7) (Fig. 4B) . When an oligomer containing the consensus DNA binding site for ETF was used, this was found to reduce formation of complexes with 7A and an oligomer containing the consensus binding site for USF completely abolished formation of a complex with 7B (Fig.  4B) . Oligomers containing consensus binding sites for other transcription factors had no effect on complex formation. We conclude that 7A binds an ETF-like factor and 7B binds USF.
An unidentified protein factor binds oligomer 1
To identify which transcription factors) binds oligomer 1, a similar strategy of using competition EMSAs was adopted. A series of unlabelled oligomers were used which contain the consensus DNA binding sites for a range of common transcription factors. Results of one such experiment are shown in Figure  5 . These data show that none of the oligomers abolishes the binding of protein factors to oligomer 1. These data, as well as data from several other such studies (not shown), have failed to Cell t\pe-dependent expression of the mouse />5.< promoter The mouse />5.* promoter constructs pAACAT and pARCAT. as well as the promoter-less (".47" construct pO.-VDM. were transfected into HeLa. CVI. L929. NRK cells and RHFs using the calcium phosphate technique 121) Plasmid DNA i 10 ".p and 10 ^g ol earner were used in each case. Sixty hours after transfection. cells were harvested and assayed for CAT ac(mt\ as described.
identify a binding activity in this region of the promoter. Consistent with these results, database "searching" with the sequence in oligomer 1 did not show a 'match' with the DNA binding site for any known transcription factor. We conclude, therefore, that an as yet unidentified transcription factor binds this region of the promoter, which we have designated PF : 2 (/>5? Factor 2).
PK2 is critical for acthit\ of the mouse p51 promoter
Previous studies have shown that the L'SF site (present in oligomer 7) is necessary for expression of the p5J promoter ! 2.1 ? i To determine whether PF2 is al so ssential. a construct was prepared in the vector pCAT.lM in which about half of the region spanned by oligomer 1 and all of the region in oligomer 2 were deleted using the technique of inverse PCR (25) . This construct is designated pAl+2CAT (Fig. 6) . Similarly, constructs were prepared which delete the promoter regions spanned by oligomer 3 (pA3CAT). oligomer 4 (pA4CAT) and oligomer 5 (pA5CAT) i Fig. 61 . These promoter deletion constructs were then transfected into REFs and W) h later CAT activities were determined as described. The results ol one such CA'I assa\ (Fig. hi showed thai pA3CAT. pA4CAT and pA5CAT were substantially (4-7-foldi reduced in CAT activity relative to pAACAT. Despite this marked reduction in transcriptional activity, the deleted promoters still remained active, as their CAT levels were 5-10-fold above the promoter-less control (pCAT3M). In addition, they are still capable of being transactivated several-fold further with serum and adenovirus Ela (T. K. Hale and A. W. Braithwaite, in preparation), as has been shown for the full-length p53 promoter (18) . The deletions in these three constructs span regions of the mouse p53 promoter which do not detectably bind protein factors in the EMSAs using NRK cell nuclear extracts (Fig. 3) . Thus, the reduced promoter activities observed with these constructs could be due to structural abnormalities caused by the deletions. By contrast, pAl+2CAT was completely defective in CAT activity (Fig. 6 ) and is not activated by serum or Ela (T. K. Hale and A. W. Braithwaite, in preparation). As the only protein factor that binds in the region spanned by the deletion is the unidentified binding activity PF2, we conclude that PF2 binding to the p53 promoter is essential for expression of this promoter.
DISCUSSION
The studies reported in this paper demonstrate several novel findings concerning the regulation of expression of the mouse p53 promoter. Using plasmid constructs in which fragments of the p53 promoter are linked to the CAT reporter gene, we provide evidence that the p53 promoter is cell type-dependent for expression (Fig. 2) , but our data provide only partial support for a negative regulatory element which has previously been reported to exist in this promoter (7) . By using a set of synthetic double-stranded oligonucleotides which correspond to different regions of the p53 promoter, spanning -224 to +101 bp. iri EMSAs with nuclear extracts of NRK cells, we have demon- strated that only three regions of the promoter bind putative transcription factors (Fig. 3) . One is an upstream region (oligomer 1), whilst the others span the CAP site (oligomer 6) and a region immediately downstream (oligomer 7). Competition EMSAs were used which allowed the identification of two of these transcription factors. NF1 was found to bind in the region of the CAP site and USF was found to bind the downstream oligomer (Fig. 4) . Both these factors have been previously reported to bind in these regions of the mouse p53 promoter (10, 12, 13) . We have also identified ETF, or an ETF-like factor, as a transcription factor that binds in close proximity to USF (Fig.  4B) . Transcription factor ETF is not a common factor, but it binds to a variety of GC-rich regions with comparable affinities. although it does exhibit a preference for long C stretches. The core sequence deduced from various binding sites is 5'-CCCC-.V (26) . Oligomer 7 contains such a sequence located between +63 and +66 bp. which is conserved across species, suggesting that this region is of general importance. Given that the competition is only partial, our data also suggest that there is a family of factors related to ETF. We were not able to identify the factor that binds the upstream region of the promoter (oligomer I) by competition HMSA (Fig.  5 ) and the DNA sequence present within oligomer I does not show homology with consensus transcription factor binding sites on computer databases. Thus, there appears to be a novel transcription factor which binds in this region of the promoter. This binding activity has been called PF2, WIT p53 Factor 2.
The O47"reporter construct pAl+2CAT (Fig. 6 ) has a deletion spanning -195 to -121 bp of the mouse p53 promoter, which includes the region -195 to -165 bp present in oligomer 1. This construct was found to be completely defective in promoter activity (Fig 6) . suggesting that PF2 is essential for activity of the mouse p53 promoter in transfected rat cells and could well represent a cell-specific factor. The result also suggests that the region to which PF2 binds is located between -195 and -169 bp of the mouse p5J promoter, within the sequence 5-C ACTCTT TTTACTTGACACAGAGGCAGGAG-3'. This sequence is highly conserved across species (7. numbering -410 to -381 bp).
Other deletion constructs show reduced promoter activities (Fig. 6) . but are not defective. We argue that these reduced activ Hies arc' most likely due to structural abnormalities caused by the deletions, as the deleted DNA fragments do not appear to bind transcription (actors under our conditions t Fig. 3 i. It could be. for example, thai ennvct sp.uiiiL between PI 2 and buvil irai'.scnp tu>n factor^ is required tor full expression of the promoter Other explanations are. however, possible Our data suggest that these other regions contained w ithin olinomers 2-5 are not essential for The data presented in this paper suggest a model in which the core' transcriptional machinery, along with the factors NFI. USF. ETF-like factor and PF2. are required for basal transcription of the mouse p53 promoter (i.e. transcription occurring under low serum conditions). We presume that binding of NFI. USF. ETF-like factor and PF2 to their respective DNA binding sites collectively enhances the formation of the pre-initiation complex on the p53 promoter, as is thought to occur for other upstream activators (27) . That these factors are likely to be essential for transcription to occur derives from our observations that on the one hand these are the only factors that bind the promoter under our experimental conditions (low serum I and on the other that deletion of the binding sites for two of them (USF (12) and PF2 (this paper)] results in little or no promoter activity Our experiments suggest that the upstream regions o\~ the mouse p53 promoter spanned by oligomers 2-5 (-169 to -1 bp).
>\hivli itk hide-the ' i(' rich reLMcii) i.ont.uninu an S^l binding sitei and the PF1 binding site, are unlikely to be important tor basal transcription (as we have defined it), as this region does not appear to bind protein (actors. Our data also suggest the possibility that the downstream ETF-like factor serves a function similar to Spl in other TATA-less promoters, stabilizing the binding of the core transcnptional complex. However, under activating conditions, such as with phorbol ester treatment, which appears to require PF1 (10), serum stimulation or infection with adenoviruses, these other regions of the promoter bind additional factors, further stimulating transcription (T. K. Hale and A. W. Braithwaite, in preparation).
In summary, we have found that basal expression of the mouse p53 promoter requires the binding of at least four transcription factors, but has the capacity to be activated further by binding different transcription factors, dependent on the stimulus. However, at least two regions are essential for activity. One of these is USF (12, 13) and the other is PF2. We are currently in the process of identifying PF2. It will be interesting to determine whether this factor is promoter-or cell type-specific or whether it is a more ubiquitous transcription factor.
